Annual EBITDA
-$240.50M$86.13M+26.37%
Summary
- Current Value
- As of today, IBRX annual EBITDA is -$240.50M, up +26.37% on
- Historical Performance
- IBRX annual EBITDA is up +26.32% over the past 3 years, down -191.59% over the past 5 years
- All-Time High Comparison
- IBRX annual EBITDA is currently -10518.19% below its historical high of -$2.27M set on
- 3-Year Low Comparison
- IBRX annual EBITDA is +29.85% above its 3-year low of -$342.85M reached on
- Sector Comparison
- IBRX annual EBITDA is higher than 5.58% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$240.50M | +26.4% | +26.3% | -191.6% | -10000.0% | |
| Quarterly EBITDA | -$57.29M | +15.0% | +27.3% | +29.4% | -6655.9% | |
| TTM EBITDA | -$235.20M | +12.6% | +32.1% | -11.4% | -10000.0% | |
| Price | $10.57 | +333.0% | +644.0% | +19.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $113.29M | +668.3% | +10000.0% | +10000.0% | +10000.0% | |
| Annual EPS | -$0.38 | +38.3% | +63.3% | +57.2% | +85.1% | |
| -$256.03M | +25.6% | +27.0% | -179.4% | -10000.0% | ||
| Annual Net Income | -$351.47M | +15.0% | +15.8% | -280.4% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$240.50M | at high | |
| 5Y | -$82.48M | N/A | -191.6% |
| All | -$2.27M | >-9999.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$342.85M | +29.9% | |
| 5Y | -$342.85M | +29.9% | |
| All | -$342.85M | +29.9% |
EBITDA History
FAQ
- What is the current annual EBITDA of IBRX?
- As of today, IBRX annual EBITDA is -$240.50M
- What is 1-year change in IBRX annual EBITDA?
- IBRX annual EBITDA is up +26.37% year-over-year
- What is 3-year change in IBRX annual EBITDA?
- IBRX annual EBITDA is up +26.32% over the past 3 years
- How far is IBRX annual EBITDA from its all-time high?
- IBRX annual EBITDA is currently -10518.19% below its historical high of -$2.27M set on December 31, 2013
- How does IBRX annual EBITDA rank versus sector peers?
- IBRX annual EBITDA is higher than 5.58% of companies in Healthcare sector
- When is IBRX next annual earnings release?
- As of today, the next annual earnings release for IBRX has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$57.29M$8.12M+12.42%
Summary
- Current Value
- As of today, IBRX quarterly EBITDA is -$57.29M, up +12.42% on
- Historical Performance
- IBRX quarterly EBITDA is up +15.01% year-over-year, up +27.32% over the past 3 years
- All-Time High Comparison
- IBRX quarterly EBITDA is currently -6655.90% below its historical high of -$848.00K set on
- 3-Year Low Comparison
- IBRX quarterly EBITDA is +39.65% above its 3-year low of -$94.93M reached on
- Sector Comparison
- IBRX quarterly EBITDA is higher than 7.60% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$57.29M | +12.4% | +15.0% | +27.3% | +29.4% | |
| Annual EBITDA | -$240.50M | – | +26.4% | +26.3% | -191.6% | |
| TTM EBITDA | -$235.20M | +4.1% | +12.6% | +32.1% | -11.4% | |
| Price | $10.57 | +19.1% | +333.0% | +644.0% | +19.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $51.24M | +15.9% | +93.9% | +10000.0% | +10000.0% | |
| Quarterly EPS | -$0.22 | +64.4% | -110.6% | +30.4% | +4.4% | |
| -$61.70M | +11.6% | +13.4% | +27.5% | +28.2% | ||
| Quarterly Net Income | -$230.39M | +63.6% | -148.9% | -66.7% | -157.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$51.68M | N/A | -10.9% |
| 3Y | -$51.68M | -10.9% | |
| 5Y | -$51.68M | -10.9% | |
| All | -$848.00K | -6655.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$65.41M | +12.4% | |
| 3Y | -$94.93M | +39.6% | |
| 5Y | -$105.30M | +45.6% | |
| All | -$105.30M | +45.6% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of IBRX?
- As of today, IBRX quarterly EBITDA is -$57.29M
- What is IBRX quarterly EBITDA most recent change?
- IBRX quarterly EBITDA was up +12.42% on June 30, 2026
- What is 1-year change in IBRX quarterly EBITDA?
- IBRX quarterly EBITDA is up +15.01% year-over-year
- How far is IBRX quarterly EBITDA from its all-time high?
- IBRX quarterly EBITDA is currently -6655.90% below its historical high of -$848.00K set on March 31, 2014
- How does IBRX quarterly EBITDA rank versus sector peers?
- IBRX quarterly EBITDA is higher than 7.60% of companies in Healthcare sector
- When is IBRX next earnings release?
- The next earnings release for IBRX is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$235.20M$10.12M+4.12%
Summary
- Current Value
- As of today, IBRX TTM EBITDA is -$235.20M, up +4.12% on
- Historical Performance
- IBRX TTM EBITDA is up +12.59% year-over-year, up +32.08% over the past 3 years
- All-Time High Comparison
- IBRX TTM EBITDA is currently -27635.61% below its historical high of -$848.00K set on
- 3-Year Low Comparison
- IBRX TTM EBITDA is +31.09% above its 3-year low of -$341.31M reached on
- Sector Comparison
- IBRX TTM EBITDA is higher than 5.89% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$235.20M | +4.1% | +12.6% | +32.1% | -11.4% | |
| Annual EBITDA | -$240.50M | – | +26.4% | +26.3% | -191.6% | |
| Quarterly EBITDA | -$57.29M | +12.4% | +15.0% | +27.3% | +29.4% | |
| Price | $10.57 | +19.1% | +333.0% | +644.0% | +19.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $165.79M | +17.6% | +192.9% | +10000.0% | +10000.0% | |
| TTM EPS | -$0.97 | -13.5% | -96.5% | +14.4% | -3.8% | |
| -$251.80M | +3.7% | +11.8% | +32.3% | -11.9% | ||
| TTM Net Income | -$992.42M | -16.1% | -170.3% | -109.3% | -343.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$235.20M | at high | |
| 3Y | -$235.20M | at high | |
| 5Y | -$235.20M | at high | |
| All | -$848.00K | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$245.31M | +4.1% | |
| 3Y | -$341.31M | +31.1% | |
| 5Y | -$346.30M | +32.1% | |
| All | -$346.30M | +32.1% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of IBRX?
- As of today, IBRX TTM EBITDA is -$235.20M
- What is IBRX TTM EBITDA most recent change?
- IBRX TTM EBITDA was up +4.12% on June 30, 2026
- What is 1-year change in IBRX TTM EBITDA?
- IBRX TTM EBITDA is up +12.59% year-over-year
- How far is IBRX TTM EBITDA from its all-time high?
- IBRX TTM EBITDA is currently -27635.61% below its historical high of -$848.00K set on March 31, 2014
- How does IBRX TTM EBITDA rank versus sector peers?
- IBRX TTM EBITDA is higher than 5.89% of companies in Healthcare sector
- When is IBRX next earnings release?
- The next earnings release for IBRX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- IBRX Official Website immunitybio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1326110/000132611026000030/0001326110-26-000030-index.htm
- IBRX Profile on Yahoo Finance finance.yahoo.com/quote/IBRX
- IBRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ibrx